Figure 2.
Timing of Initiation of New Preventive Therapies
Cumulative events from clinic consultation to the dispensing of: (A) antiplatelet therapy (hazard ratio: 12.17 [95% confidence interval: 7.52 to 19.71]; p < 0.0001) and (B) statin therapy (hazard ratio: 3.49 [95% confidence interval: 2.63 to 4.42]; p < 0.0001), according to trial allocation. Orange line indicates coronary computed tomography angiography + standard care. Blue line indicates standard care alone.
